Patent Assignment
Reel/Frame 065636/0120
Assignment of Assignor's Interest
Recorded: 2023-11-21
Pages: 3
Assignor
FITZGERALD, KEVIN
Executed: 2015-10-02
Assignee
ALNYLAM PHARMACEUTICALS, INC.
300 THIRD STREET, 3RD FLOOR, CAMBRIDGE, MASSACHUSETTS, 02142-1110
Covered Property
(1)
Methods and Compositions for Treating a Proprotein Convertase Subtilisin Kexin (PCSK9) Gene-Associated Disorder
Application:
18/507,175 →
Publication:
US 2024/0301425